Jaiswal Varun, Lee Hae-Jeung
Department of Food and Nutrition, College of BioNano Technology, Gachon University, 1342 Seongnam-daero, Sujeong-gu, Seongnam-si 13120, Republic of Korea.
Institute for Aging and Clinical Nutrition Research, Gachon University, Seongnam-si 13120, Republic of Korea.
Molecules. 2024 Dec 12;29(24):5871. doi: 10.3390/molecules29245871.
(HA) is a monotypic tree species used as traditional medicine against various diseases and conditions in African countries. HA is also a multipurpose plant used for furniture, fuel wood, soil fertility management, and rainwater conservation, along with medicinal usage. In different in vitro, in vivo, ex vivo, and human studies, the potential of HA for different pharmacological properties, including anti-parasite, antibacterial, antifungal, antispasmodic, anticancer, anti-diabetes, antidiarrheal, wound healing, antioxidant, and anti-inflammatory activities were observed. Antioxidant and anti-inflammation properties of HA may be the primary reason for the multi-pharmacological activities of HA. Initial toxicity studies and the presence of various phytochemicals, especially flavonoids, also support the therapeutic potential of HA. The diverse medicinal properties of the plant have different challenges to overcome for its development. Limited studies to decipher the molecular mechanism behind the pharmacological activity restrict the utilization of the complete potential of HA as therapeutics. Still, the compilation of phytochemical, pharmacological activities, and target pathways of HA is missing in the literature. The current review not only compiles the pharmacological activities and phytochemicals but also highlights the gaps and proposes the future direction to develop HA as a candidate against important diseases.
哈尼亚(HA)是一种单型树种,在非洲国家被用作治疗各种疾病和病症的传统药物。哈尼亚也是一种多用途植物,除药用外,还用于制作家具、提供薪柴、管理土壤肥力和雨水收集。在不同的体外、体内、离体和人体研究中,观察到哈尼亚具有不同药理特性的潜力,包括抗寄生虫、抗菌、抗真菌、解痉、抗癌、抗糖尿病、止泻、伤口愈合、抗氧化和抗炎活性。哈尼亚的抗氧化和抗炎特性可能是其多种药理活性的主要原因。初步毒性研究以及各种植物化学物质(尤其是黄酮类化合物)的存在也支持了哈尼亚的治疗潜力。该植物多样的药用特性在其开发过程中有不同的挑战需要克服。用于解读其药理活性背后分子机制的研究有限,限制了哈尼亚作为治疗药物全部潜力的利用。然而,文献中缺少哈尼亚的植物化学成分、药理活性和靶标途径的汇编。本综述不仅汇编了其药理活性和植物化学成分,还突出了差距,并提出了将哈尼亚开发成治疗重要疾病候选药物的未来方向。